Mackenzie Financial Corp increased its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 39.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 128,521 shares of the technology company’s stock after buying an additional 36,232 shares during the quarter. Mackenzie Financial Corp’s holdings in Amdocs were worth $10,143,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of DOX. Norwood Financial Corp bought a new stake in shares of Amdocs in the 1st quarter worth about $33,000. Central Pacific Bank Trust Division purchased a new stake in Amdocs in the 1st quarter worth about $53,000. Riverview Trust Co bought a new stake in Amdocs in the first quarter worth about $55,000. Quarry LP boosted its position in shares of Amdocs by 168.9% during the fourth quarter. Quarry LP now owns 656 shares of the technology company’s stock valued at $58,000 after buying an additional 412 shares during the period. Finally, American National Bank bought a new position in shares of Amdocs during the second quarter valued at approximately $76,000. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Price Performance
Shares of DOX stock opened at $87.48 on Tuesday. The company has a market capitalization of $10.28 billion, a P/E ratio of 19.66, a P/E/G ratio of 1.54 and a beta of 0.74. The company’s 50-day simple moving average is $85.24 and its two-hundred day simple moving average is $83.75. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24.
Amdocs Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date is Monday, September 30th. Amdocs’s dividend payout ratio (DPR) is presently 42.92%.
Wall Street Analyst Weigh In
Separately, StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 13th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Amdocs has an average rating of “Buy” and an average target price of $102.50.
Check Out Our Latest Stock Analysis on Amdocs
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
- Five stocks we like better than Amdocs
- 5 discounted opportunities for dividend growth investors
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What Investors Need to Know to Beat the Market
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- What is Short Interest? How to Use It
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.